Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections

Topline Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth-straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm...